During the regulatory review, agencies thoroughly examine the submitted data from both preclinical and clinical studies. This includes:
Evaluating the treatment's efficacy and safety profile. Reviewing manufacturing processes to ensure quality and consistency. Assessing the risk-benefit ratio for the intended population.
Regulatory agencies may also seek advice from advisory committees comprising independent experts.
